Table 1 Characteristics of study subjects
Variable | Total (n = 1447) | Middle-Aged Group (n = 791) | Older Group (n = 656) | |||
|---|---|---|---|---|---|---|
HUA (n = 279) | Non-HUA (n = 1168) | HUA (n = 146) | Non-HUA (n = 645) | HUA (n = 133) | Non-HUA (n = 523) | |
Age, y | 64.0 (59.0–69.0) | 63.0 (58.0–69.0) | 59.5 (55.0–62.0) | 59.0 (55.0–62.0) | 69.0 (67.0–73.5) | 70.0 (67.0–75.0) |
Duration of T2DM, y | 11.0 (6.0–19.0) | 10.0 (4.0–16.0)** | 10.0 (5.0–15.3) | 9.0 (4.0–13.0)* | 14.0 (8.0–20.0) | 12.0 (5.0–20.0) |
BMI, kg/m2 | 25.7 (24.0–27.5) | 24.5 (22.5–26.4)** | 25.8 (24.2–27.8) | 24.6 (22.6–26.8)** | 25.6 (23.6–27.4) | 24.4 (22.3–26.1)** |
WC, cm | 96.0 (90.0–100.2) | 92.0 (87.0–98.0)** | 96.0 (89.8–102.0) | 92.0 (87.0–98.0)** | 96.0 (90.0–100.0) | 92.0 (87.0–98.0)* |
HC, cm | 100.0 (94.0–104.0) | 97.0 (92.0–101.8)** | 100.0 (94.0–104.3) | 97.0 (92.0–101.5)** | 100.0 (95.0–103.5) | 97.0 (92.0–102.0)* |
WHR | 0.96 (0.93–1.00) | 0.96 (0.92–0.99) | 0.96 (0.93–1.00) | 0.96 (0.93–0.99) | 0.96 (0.93–0.99) | 0.96 (0.91–0.99)* |
WHtR | 0.56 (0.53–0.59) | 0.54 (0.51–0.58)** | 0.55 (0.52–0.59) | 0.54 (0.51–0.57)** | 0.57 (0.53–0.60) | 0.54 (0.51–0.58)* |
UA, mg/dl | 7.7 (7.3–8.4) | 5.3 (4.5–6.0)** | 7.8 (7.4–8.5) | 5.3 (4.5–6.1)** | 7.6 (7.2–8.4) | 5.3 (4.6–6.0)** |
FPG, mg/dl | 125.8 (106.7–155.1) | 136.6 (110.1–172.5)** | 125.9 (107.1–157.9) | 142.0 (113.5–178.6)** | 123.1 (104.3–152.8) | 132.3 (106.8–167.4) |
FINS, μIU/mL | 9.7 (6.2–15.1) | 8.4 (5.3–12.6)* | 9.3 (5.8–13.9) | 8.0 (5.0–12.0)* | 10.7 (6.4–17.7) | 9.1 (5.6- 13.3)* |
HOMA-IR | 3.0 (1.8–5.4) | 2.9 (1.7–4.8) | 2.9 (1.8–4.5) | 2.9 (1.7–4.6) | 3.2 (1.9–6.1) | 3.0 (1.7–4.9) |
HOMA-β | 55.0 (34.4–101.0) | 41.1 (23.1–75.6)** | 50.2 (34.0–86.7) | 36.7 (22.2–65.3)** | 59.9 (34.9–130.8) | 48.1 (25.0–93.9)* |
ALT, U/L | 19.0 (14.0–29.0) | 18.0 (13.0–26.0) | 21.0 (15.0–32.0) | 19.0 (14.0–28.0) | 18.0 (12.0–26.0) | 17.0 (13.0–25.0) |
AST, U/L | 19.0 (16.0–24.0) | 18.0 (15.0–23.0)* | 19.0 (16.0–25.0) | 18.0 (15.0–24.0) | 20.0 (16.0–24.0) | 18.0 (15.0–23.0) |
TG, mg/dl | 174.3 (123.0–268.1) | 123.0 (87.6–183.2)** | 187.6 (132.5–281.9) | 132.7 (94.7–194.7)** | 155.8 (113.7–238.9) | 113.3 (81.4–162.0)** |
TC, mg/dl | 164.9 (135.1–190.3) | 160.6 (136.7–188.8) | 162.0 (136.7–191.1) | 166.8 (141.9–195.4) | 169.1 (134.2–188.2) | 154.4 (129.3–180.0) |
HDL-C, mg/dl | 40.2 (35.1–46.3) | 43.6 (37.5–51.1)** | 40.0 (34.4–45.2) | 43.6 (37.5–51.0)** | 40.2 (35.7–47.1) | 43.2 (37.5–51.4)* |
LDL-C, mg/dl | 96.5 (75.3–117.4) | 92.3 (72.6–115.1) | 97.1 (76.1–118.1) | 96.9 (76.4–118.0) | 96.5 (68.1–116.6) | 88.4 (67.2–110.8) |
eGFR, mL/min/1.37m2 | 93.5 (72.9–118.2) | 119.7 (98.9–142.7)** | 103.6 (76.7–122.4) | 125.6 (106.6–149.7)** | 87.0 (67.4–107.5) | 112.2 (90.6–131.6)** |
SBP, mm Hg | 134.0 (126.0–149.0) | 131.0 (125.0–146.0) | 133.0 (125.0- 149) | 130.0 (123.0–143.0) | 135.0 (127.0–150.0) | 134.0 (126.0–149.0) |
DBP, mm Hg | 75.0 (70.0–85.0) | 75.0 (70.0–85.0) | 77.0 (70.0–87.0) | 78.0 (70.0–86.0 | 72.0 (70.0–83.0) | 73.0 (69.0–81.0) |